C CRSP

CRISPR Therapeutics AG

$49.57

+3.29% (+$1.58)

Volume 1.40M

52W High $78.48

52W Low $44.12

Market Cap $4.60B

Next Earnings Report

No earnings data available for CRSP

Last 9 quarters

Q1 2026 May 11, 2026

1-Day: -2.18%

Q1 2026 May 5, 2026

1-Day: +5.15%

Q1 2026 May 4, 2026

1-Day: -2.24%

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q4'25	$864,000	-97.5%	-6,770.8%	-10,000.0%	-$130.6M
Q3'25	$889,000	+47.7%	-7,177.1%	-10,000.0%	-$106.4M
Q2'25	$892,000	+72.5%	-5,062.0%	-10,000.0%	-$208.5M
Q1'25	$865,000	+71.6%	-6,548.4%	-10,000.0%	-$136.0M
Q4'24	$35.0M	-82.5%	100.0%	-184.5%	-$37.3M
Q3'24	$602,000	-99.1%	-1,852.7%	-10,000.0%	-$85.9M
Q2'24	$517,000	-99.5%	-10,000.0%	-10,000.0%	-$126.4M
Q1'24	$504,000	+8,300.0%	-10,000.0%	-10,000.0%	-$116.6M

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q2 2026	Aug 3, 2026	-$1.11	-$1.11	--	--	--
Q1 2026	May 11, 2026	-$1.10	-$1.10	-$1.28	-16.36%	Missed
Q1 2026	May 5, 2026	-$1.14	-$1.14	--	--	--
Q1 2026	May 4, 2026	-$1.23	-$1.10	-$1.28	-4.07%	Missed
Q4 2025	Feb 17, 2026	-$1.17	-$1.17	-$1.37	-17.09%	Missed
Q4 2025	Feb 12, 2026	-$1.23	-$1.17	-$1.37	-11.38%	Missed
Q4 2025	Feb 10, 2026	-$1.15	-$1.15	--	--	--
Q3 2025	Nov 10, 2025	-$1.29	-$1.31	-$1.17	+9.30%	Beat
Q3 2025	Nov 5, 2025	-$1.31	-$1.31	-$1.17	+10.69%	Beat
Q2 2025	Aug 4, 2025	-$1.40	-$1.40	-$1.29	+7.86%	Beat
Q1 2025	May 6, 2025	-$1.28	-$1.28	-$1.58	-23.44%	Missed
Q4 2024	Feb 11, 2025	-$1.19	-$1.19	-$0.44	+62.89%	Beat